ClinicalTrials.gg
Active, not recruitingNCT07937241Updated Nov 16, 2026

The Effects of Rotating Sensory Toys and Parental Presence During Peripheral Intravenous Cannulation in Infants

An interventional study of Rotating Sensory Toy Set and Parental Presence Group in Pain Management, sponsored by Aylin Kurt. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 1 Month to 24 Months. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Aylin Kurt · Not applicable, Interventional, and Health services research

Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
1 Month to 24 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 1,720 studies in Pain with a site in Turkey — 323 open to participants now, 376 under way, none of them phase 3. Pain · Turkey.

Planned enrollment
137th of 1,497
130 · median 70
Started
2026
with 183 others
No phase
1,455 of 1,720
261 open now
Primary completion
2027-06
later than 349 of 375 live
Registered
1,719th of 1,720
by date

Among the 1,720 studies in Pain with a site in Turkey, this one is the 137th largest by planned enrollment of the 1,497 interventional ones that give a count, is one of 184 that started in 2026, is one of 1,455 with no phase, reaches primary completion later than 349 of the 375 other live ones, and was the 1,719th registered.

Pain

10,069 studies on the registry are indexed under Pain; 1,650 are open to participants now.

Browse Pain studies →

Open to participants now

323 of the 1,720 studies in Pain with a site in Turkey are open now. Recruiting first, the newest first:

318 more — sign in →

All 323 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 927 Pain studies recruiting now, 382 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 221 take healthy volunteers.

This study: 1 Month to 24 Months · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,720 studies in Pain with a site in Turkey, or all of them as a file.
02

Study summary

Peripheral intravenous cannulation is one of the most frequently performed invasive procedures in infants and can cause pain, physiological stress, and behavioral distress. The use of non-pharmacological methods is increasingly important to reduce negative experiences during the procedure. This research was planned to evaluate the effect of a rotating sensory toy and parental presence on pain and clinically relevant outcomes during peripheral intravenous cannulation in infants aged 1-24 months. The study will be conducted as a three-arm, parallel-group, randomized controlled trial in the Pediatric Ward of Bartın State Hospital. The sample will consist of a total of 150 infants who agree to participate and meet the inclusion criteria. Participants will be assigned to three groups using a computer-based block randomization method: a rotating sensory toy group, a parental presence group, and a control group. The primary outcome variable of the study is pain level, assessed using the FLACC Pain Scale. Secondary outcome variables are crying duration, heart rate, oxygen saturation, procedure time, successful intravenous access on the first attempt, and parental and nurse satisfaction. FLACC scores will be assessed by an independent pediatric nurse unaware of the investigator and group assignments to reduce observer bias. The findings of this study are expected to provide evidence for effective, safe, and low-cost non-pharmacological interventions that can be applied during peripheral intravenous cannulation and to contribute to pediatric nursing practice.

Read the detailed description

Peripheral intravenous cannulation is one of the most frequently performed invasive procedures in infants and can cause pain, physiological stress, and behavioral distress. The use of non-pharmacological methods is increasingly important to reduce negative experiences during the procedure. This research was planned to evaluate the effect of a rotating sensory toy and parental presence on pain and clinically relevant outcomes during peripheral intravenous cannulation in infants aged 1-24 months. The study will be conducted as a three-arm, parallel-group, randomized controlled trial in the Pediatric Ward of Bartın State Hospital. The sample will consist of a total of 150 infants who agree to participate and meet the inclusion criteria. Participants will be assigned to three groups using a computer-based block randomization method: a rotating sensory toy group, a parental presence group, and a control group. The primary outcome variable of the study is pain level, assessed using the FLACC Pain Scale. Secondary outcome variables are crying duration, heart rate, oxygen saturation, procedure time, successful intravenous access on the first attempt, and parental and nurse satisfaction. FLACC scores will be assessed by an independent pediatric nurse unaware of the investigator and group assignments to reduce observer bias. The findings of this study are expected to provide evidence for effective, safe, and low-cost non-pharmacological interventions that can be applied during peripheral intravenous cannulation and to contribute to pediatric nursing practice.

03

Conditions studied

  • Pain Management

Browse trials for

Keywords

  • pain
  • nurse
  • infants
  • parents
04

Who can participate

Ages eligible
1 Month to 24 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between 1 and 24 months old,
  • Being hospitalized in the Pediatric Ward of Bartın State Hospital,
  • Having been decided upon by a physician for peripheral intravenous cannulation,
  • Having a stable general clinical condition,
  • Having given written for participation in the study by a parent or legal guardian.

Exclusion criteria

Exclusion Criteria:

  • Having a condition that may affect the response to sensory stimuli, such as visual or hearing loss,
  • Having a neurological disease, developmental delay, or a disease that may affect behavioral responses,
  • Using or having taken sedative, opioid, or general anesthetic drugs that affect the level of consciousness within the last 24 hours,
  • Receiving mechanical ventilation support,
  • Being hemodynamically unstable,
  • Being in a critical clinical condition requiring emergency resuscitation,
  • Having a congenital anomaly, burn, trauma, or infection in the extremity where intravenous access will be established,
  • The parent wishing to withdraw from the study or being unable to complete the research process.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Investigator)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    Experimental_1

    Other: Rotating Sensory Toy Set

  • Experimental
    Experimental_2

    Other: Parental Presence Group

  • No intervention
    Control

Interventions

  • OtherRotating Sensory Toy Set

    In this study, a rotating sensory toy that can be attached to flat surfaces with a suction cup, rotates 360°, and emits colorful and soft sounds will be used as a distraction method. The toy will be fixed to the edge of the stretcher/wall where the baby can easily see it. Approximately one minute before the peripheral intravenous cannulation procedure, the toy will be rotated to direct the baby's attention to it. The toy will continue to be rotated by the researcher throughout the procedure, and the baby will be encouraged to watch or touch the toy.

  • OtherParental Presence Group

    In this group, the parent will be present with the baby throughout the procedure. The parent will be asked to touch the baby, speak to it in a calm tone, make eye contact, and engage in soothing behaviors. No other distraction methods will be used.

06

What researchers measure

Primary outcomes

  1. FLACC Pain Scale (Face, Legs, Activity, Cry, Consolability)

    The FLACC (Face, Legs, Activity, Cry, Consolability) Pain Scale will be used to assess the pain level of infants during and after the procedure. The scale consists of five behavioral dimensions: face, legs, activity, cry, and consolability. Each dimension is scored between 0, 1, and 2 points, with a total score ranging from 0 to 10. An increase in the scale score indicates increased pain intensity (Şenaylı et al., 2006). The primary outcome was the child's pain level, assessed using the Face, Legs, Activity, Cry, and Consolability (FLACC) scale during the procedure (T1) and immediately after the procedure (T2). It was hypothesized that children in the intervention groups would have lower FLACC scores during and immediately after the procedure compared with those in the control group.

    Time frame: 6 months

Secondary outcomes

  1. Heart rate

    Heart rate was assessed before (T0), during (T1), and immediately after the procedure (T2). It was hypothesized that children in the intervention groups would demonstrate more stable heart rates, with values closer to their baseline levels, during and immediately after the procedure compared with those in the control group.

    Time frame: 8 month

  2. Peripheral oxygen saturation (SpO₂)

    Peripheral oxygen saturation was assessed before, during, and immediately after the procedure. It was hypothesized that children in the intervention groups would have more stable SpO₂ levels compared with those in the control group.

    Time frame: 8 months

  3. Duration of crying

    The duration of crying was recorded during the procedure. It was hypothesized that children in the intervention groups would have shorter crying durations compared with those in the control group.

    Time frame: 8 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Jun 2027, 9 months after the start.

Of 3,740 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 9 months is close to that.

Counting every sponsor, half of 3,839 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2026
First posted
Nov 16, 2026
StartActual
Sep 1, 2026
Primary completionEst.
Jun 1, 2027
CompletionEst.
Sep 1, 2027
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07937241
Lead sponsor
Aylin Kurt
Collaborators
Bartın Unıversity
Responsible party
Aylin Kurt (Asst. prof., Bartın Unıversity) — Sponsor-investigator
First posted
Nov 16, 2026
Start date
Sep 1, 2026
Primary completion
Jun 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion